GSK Consumer Health
The Latest
-
Unilever Facing Growing Investor Backlash Over GSK Bid
Unilever is facing increased investors backlash from both sides following reports of its $95 billion bid to acquire GSK's consumer health unit. Unilever is facing increased investors backlash from both sides following reports of its $95 billion bid to acquire GSK's consumer health unit.